Edoardo Simonetti

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Journal: HemaSphere
Published: April 30, 2026

Effect of a 2-h daily exit on milk quality, activities and outside behavior of lactating cows.

Effect of a 2-h daily exit on milk quality, activities and outside behavior of lactating cows.

Journal: Frontiers in veterinary science
Published: April 08, 2026

Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma.

Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: March 14, 2026

Effect of a daily outdoor access on milk quality and behavior of Italian Simmental dairy cows.

Effect of a daily outdoor access on milk quality and behavior of Italian Simmental dairy cows.

Journal: Frontiers in veterinary science
Published: July 04, 2025

Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study.

Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 26, 2025

Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series.

Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series.

Journal: Frontiers in immunology
Published: August 10, 2024

Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.

Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.

Journal: International journal of antimicrobial agents
Published: January 16, 2023

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.

Journal: Blood cancer journal
Published: March 02, 2022

Choroidal vasculature analysis in MEK inhibitor-associated retinopathy.

Choroidal vasculature analysis in MEK inhibitor-associated retinopathy.

Journal: European journal of ophthalmology
Published: February 23, 2022

Visceral Leishmaniasis Associated with B-Cell Chronic Lymphocytic Leukemia: Report of a Case and Review of the Literature.

Visceral Leishmaniasis Associated with B-Cell Chronic Lymphocytic Leukemia: Report of a Case and Review of the Literature.

Journal: Life (Basel, Switzerland)
Published: December 26, 2021

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.

Journal: The New England journal of medicine
Published: May 12, 2021

Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.

Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.

Journal: Leukemia
Published: November 19, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026